Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004167430 | SCV003657053 | uncertain significance | not specified | 2022-11-10 | criteria provided, single submitter | clinical testing | The c.1613T>C (p.L538P) alteration is located in exon 3 (coding exon 3) of the NPC1L1 gene. This alteration results from a T to C substitution at nucleotide position 1613, causing the leucine (L) at amino acid position 538 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |